NCT06481111 Prospective Monocentric Registry of Patients Undergoing Vitamin D Treatment at San Raffaele Hospital
| NCT ID | NCT06481111 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS San Raffaele |
| Condition | Hypovitaminosis D |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-07-10 |
| Primary Completion | 2029-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-07-10 with a primary completion date of 2029-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Endocrinology Unit of the IRCCS San Raffaele Hospital is dedicated to establishing a prospective single-center registry with data from patients undergoing vitamin D supplementation, initiating their first visit to the outpatient unit until December 2029. 1000 patients will be enrolled, aligning with the unit's recent patient influx for hypovitaminosis D. The registry's goal is to assess the epidemiological trend, identify risk factors, and evaluate the diagnostic and therapeutic clinical management strategies for hypovitaminosis D. It will involve collecting clinical, laboratory, and historical data during outpatient visits, adhering to the standard diagnostic and therapeutic protocols for endocrine-metabolic diseases. This data collection is expected to continue for a duration of ten years.
Eligibility Criteria
Inclusion Criteria: * Adult men and women (age ≥ 18 years) regardless of fertility status and pregnancy/breastfeeding conditions * Vitamin D supplementation, with any formulation and dosage * Signing of informed consent Exclusion Criteria: * Patients unable to understand and sign informed consent.
Contact & Investigator
Luigi di Filippo, MD
PRINCIPAL INVESTIGATOR
IRCCS San Raffaele
Frequently Asked Questions
Who can join the NCT06481111 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypovitaminosis D. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06481111 currently recruiting?
Yes, NCT06481111 is actively recruiting participants. Contact the research team at difilippo.luigi@hsr.it for enrollment information.
Where is the NCT06481111 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06481111 clinical trial?
NCT06481111 is sponsored by IRCCS San Raffaele. The principal investigator is Luigi di Filippo, MD at IRCCS San Raffaele. The trial plans to enroll 1,000 participants.